|
|
|
Volumn 20, Issue 3, 2003, Pages 38-42
|
|
Use of intermittent or continuous interstitial fluid glucose monitoring in patients with diabetes mellitus.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARTICLE;
BIOMEDICAL TECHNOLOGY ASSESSMENT;
BLOOD GLUCOSE MONITORING;
CHEMISTRY;
COMPARATIVE STUDY;
DIABETES MELLITUS;
EVALUATION;
EXTRACELLULAR FLUID;
FOOD AND DRUG ADMINISTRATION;
GLUCOSE BLOOD LEVEL;
HEALTH INSURANCE;
HUMAN;
INSURANCE;
METHODOLOGY;
NATIONAL HEALTH INSURANCE;
OUTCOME ASSESSMENT;
REPRODUCIBILITY;
SAFETY;
UNITED STATES;
BLOOD GLUCOSE;
BLOOD GLUCOSE SELF-MONITORING;
BLUE CROSS;
BLUE SHIELD;
DEVICE APPROVAL;
DIABETES MELLITUS;
EVALUATION STUDIES;
EXTRACELLULAR FLUID;
HUMANS;
INSURANCE COVERAGE;
OUTCOME ASSESSMENT (HEALTH CARE);
REPRODUCIBILITY OF RESULTS;
TECHNOLOGY ASSESSMENT, BIOMEDICAL;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 1842557760
PISSN: None
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|